English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 15 November 2023, 20:00 HKT/SGT

Source: Envision Pharma Group
Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
The new board and leadership appointment aligns with the company's commitment to advancing the industry through innovation and the expansion of AI across its solutions

HORSHAM, UK, Nov 15, 2023 - (ACN Newswire) - Envision Pharma Group (Envision), a leading global technology-enabled strategic solutions partner for the life sciences industry, unveils its AI Innovation Board and announces the appointment of Dr. Loubna Bouarfa as AI thought leader and Chairwoman of the newly established board. This strategic move underscores Envision's global commitment to harnessing the power of AI to shape the future of the life sciences industry.

Previously serving as the CEO and founder of OKRA.ai, which was acquired by Envision in February 2023, Dr. Bouarfa revolutionized healthcare by creating AI systems that support life sciences companies to better enable the drive of personalized medicine across the globe. In this new role, she will apply her deep expertise to intertwine AI with all the services that Envision offers.

"Loubna's appointment and the establishment of the new AI Innovation Board marks a significant step toward aligning our innovation and technology efforts to drive our strategies for our internal team, business, and partners," shares Howard Miller, CEO of Envision Pharma Group. "We are confident this strategic move will propel Envision to new heights."

In her new role, Dr. Bouarfa will focus on advancing AI strategy and promoting its integration across all aspects of Envision. This appointment solidifies Envision's dedication to leveraging AI to deliver innovative, faster outcomes for the life sciences industry. In addition, Dr. Bouarfa will lead the AI Innovation Board to define and develop Envision's AI strategy across all technology platforms, solidify thought leadership as pioneers in AI, and pilot new innovative AI applications.

Having earned the Deloitte Fast 50 Women in Leadership Award and a place on Forbes' 50 Top Women in Tech list, Dr. Bouarfa expressed her commitment to the role, saying, "I am excited to take on this new challenge and continue driving AI innovation at Envision. We are dedicated to leading the industry in this space and delivering innovative solutions that will transform the future of life sciences. Our success will not only bring commercial benefit to clients but lead to improved patient outcomes across the globe."

About Envision Pharma Group

Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 19 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Learn more at www.envisionpharmagroup.com.

Contact Information
Colleen Carter
Associate Director, Communications, Office of CEO
1 (508) 505 8856

Topic: Press release summary
Source: Envision Pharma Group

Sectors: BioTech, Healthcare & Pharm, HR
From the Asia Corporate News Network

Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Envision Pharma Group Related News
Jan 18, 2024 20:00 HKT/SGT
Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer
Jan 16, 2024 20:00 HKT/SGT
Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC)
June 15, 2023 19:00 HKT/SGT
OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position
May 10, 2023 14:00 HKT/SGT
Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors
May 10, 2023 14:00 HKT/SGT
Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575